Moderna Sets High Coronavirus Vaccine Pricing Bar In Small, Early Deals

The company has executed $400m worth of deals with smaller governments reflecting a $32-$37 price per dose for the two-shot mRNA-1273 vaccine, but said larger deals will be done at lower prices.

Bottles coronavirus vaccine. sars-cov-2 / COVID-19. Some ampoules with ncov-2019 vaccine in a box. to fight the coronavirus pandemic.
Moderna raised its 2020 cash burn guidance, primarily to cover mRNA-1273 manufacturing costs • Source: Shutterstock

Moderna, Inc.’s initial deals for purchases of mRNA-1273, its messenger RNA (mRNA) vaccine against SARS-CoV-2, set a relatively high per-dose price of $32-$37. However, these first deals with smaller governments total just $400m to date, as opposed to the multibillion-dollar deals the US has made with other vaccine makers, and in those kinds of high-volume deals the company said its price per dose is likely to be lower.

Pfizer Inc. and BioNTech SE effectively set a $19.50 price per dose last month with the $1.95bn deal...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip